Organoid Cultures Derived from Patients with Advanced Prostate Cancer
Gao, Dong, Vela, Ian, Sboner, Andrea, Iaquinta, Phillip J., Karthaus, Wouter R., Gopalan, Anuradha, Dowling, Catherine, Wanjala, Jackline N. +31 more·2014·Cell
Cited by (1,000)
Items 401–500 of 1,000
- Identification of Different Classes of Luminal Progenitor Cells within Prostate TumorsSupreet Agarwal, Paul G. Hynes, Heather Sheppard, Ross G. Lake, Wassim G. Abou-Kheir, Lei Fang, Orla M. Casey, Amir H. Ameri, Philip L. Martin, Juan Juan Yin et al. · 2015 · Cell Reports
- The Genomics of Prostate Cancer: emerging understanding with technologic advancesMark A. Rubin, Francesca Demichelis · 2018 · Modern Pathology
- Characterization of single circulating tumor cellsCatherine Alix‐Panabières, Klaus Pantel · 2017 · FEBS Letters
- Advances on colorectal cancer 3D models: The needed translational technology for nanomedicine screeningFlávia Castro, Catarina Leite Pereira, Maria Helena Macedo, Andreia Almeida, Maria José Silveira, Sofia Dias, Ana Patrícia Cardoso, María José Oliveira, Bruno Filipe Carmelino Cardoso Sarmento · 2021 · Advanced Drug Delivery Reviews
- Organoids in high-throughput and high-content screeningsFranziska L. Lampart, Dagmar Iber, Nikolaos Doumpas · 2023 · Frontiers in Chemical Engineering
- Cellular self-assembly and biomaterials-based organoid models of development and diseasesShivem B. Shah, Ankur K. Singh · 2017 · Acta Biomaterialia
- Detection of CTCs in portal vein was associated with intrahepatic metastases and prognosis in patients with advanced pancreatic cancerXiaoyu Liu, Changyu Li, Junhao Li, Tianzhu Yu, Guofeng Zhou, Jiemin Cheng, Guoping Li, Yang Zhou, Wenhui Lou, Xiaolin Wang et al. · 2018 · Journal of Cancer
- Loss of SYNCRIP unleashes APOBEC-driven mutagenesis, tumor heterogeneity, and AR-targeted therapy resistance in prostate cancerXiaoling Li, Yunguan Wang, Su Deng, Guanghui Zhu, Choushi Wang, Nickolas A. Johnson, Zeda Zhang, Carla R. Tirado, Yaru Xu, Lauren A. Metang et al. · 2023 · Cancer Cell
- Cancer organoids: A platform in basic and translational researchXin Ma, Qin Lin Wang, Guozheng Li, Hui Li, Shouping Xu, Da Pang · 2023 · Genes & Diseases
- Initiation, Expansion, and Cryopreservation of Human Primary Tissue‐Derived Normal and Diseased Organoids in Embedded Three‐Dimensional CultureJames Clinton, Penney McWilliams‐Koeppen · 2018 · Current Protocols in Cell Biology
- Two-Step Acoustophoresis Separation of Live Tumor Cells from Whole BloodEva Undvall Anand, Cecilia Magnusson, Andreas Lenshof, Yvonne Ceder, Hans G. Lilja, Thomas Laurell · 2021 · Analytical Chemistry
- Exploring the Clinical Utility of Pancreatic Cancer Circulating Tumor CellsDannel Yeo, Althea Bastian, Heidi Strauss, Payal Saxena, Peter Grimison, John E.J. Rasko · 2022 · International Journal of Molecular Sciences
- Correlation between drug sensitivity profiles of circulating tumour cell-derived organoids and clinical treatment response in patients with pancreatic ductal adenocarcinomaYuan‐Hung Wu, Yi‐Ping Hung, Nai‐Chi Chiu, Rheun‐Chuan Lee, Chung‐Pin Li, Yee Chao, Yi‐Ming Shyr, Shin‐E Wang, Shih‐Chin Chen, Sheng‐Hsuan Lin et al. · 2022 · European Journal of Cancer
- Patient-derived tumor organoids: A preclinical platform for personalized cancer therapySébastien Taurin, Reem Alzahrani, Sahar Aloraibi, Layal Ashi, Rawan A Rahman AlHarmi, Noora Hassani · 2024 · Translational Oncology
- Cancer stem cells: at the forefront of personalized medicine and immunotherapyMicol Eleonora Fiori, Lidia Villanova, Ruggero D. Maria · 2017 · Current Opinion in Pharmacology
- Kidney organoids in translational medicine: Disease modeling and regenerative medicineTomoya Miyoshi, Ken Hiratsuka, Edgar Garcia Saiz, Ryuji Morizane · 2019 · Developmental Dynamics
- Tumor antigen-independent and cell size variation-inclusive enrichment of viable circulating tumor cellsWujun Zhao, Yang Liu, Brittany Denise Jenkins, Rui Cheng, Bryana N. Harris, Weizhong Zhang, Jin Xie, Jonathan R. Murrow, Jamie Hodgson, Mary Egan et al. · 2019 · Lab on a Chip
- Organoid of ovarian cancer: genomic analysis and drug screeningHuidong Liu, Bairong Xia, Mingzhu Jin, Ge Lou · 2020 · Clinical & Translational Oncology
- Screening Cancer Immunotherapy: When Engineering Approaches Meet Artificial IntelligenceXingwu Zhou, Moyuan Qu, Peyton J. Tebon, Xing Jiang, Canran Wang, Yumeng Xue, Jixiang Zhu, Shiming Zhang, Rahmi Öklü, Shiladitya Sengupta et al. · 2020 · Advanced Science
- The promises and challenges of patient‐derived tumor organoids in drug development and precision oncologyLauren M. Granat, Ooha Kambhampati, Stephanie Klosek, Brian Niedzwecki, Kian Parsa, Dong Zhang · 2019 · Animal Models and Experimental Medicine
- The functional and clinical roles of liquid biopsy in patient-derived modelsZiqing Zhu, Erya Hu, Hong Shen, Jun Tan, Shan Zeng · 2023 · Journal of Hematology & Oncology
- Organoids from pituitary as a novel research model toward pituitary stem cell explorationBenoit Cox, Emma Laporte, Annelies Vennekens, Hiroto Kobayashi, Charlotte Nys, Indra Van Zundert, Hiroshi Uji‐i, Alizée Vercauteren Drubbel, Benjamin Beck, Heleen Roose et al. · 2018 · Journal of Endocrinology
- Progress in human liver organoidsLulu Sun, Lijian Hui · 2020 · Journal of Molecular Cell Biology
- Metabolic regulation of prostate cancer heterogeneity and plasticityClaudia Peitzsch, Ielizaveta Gorodetska, Daria Klusa, Qihui Shi, Tiago C. Alves, Klaus Pantel, Anna Dubrovska · 2020 · Seminars in Cancer Biology
- The Impact of PIK3R1 Mutations and Insulin–PI3K–Glycolytic Pathway Regulation in Prostate CancerGoutam Chakraborty, Subhiksha Nandakumar, Rahim Hirani, Bastien Nguyen, Konrad Hermann Stopsack, Christoph K. Kreitzer, Sai Harisha Rajanala, Romina Ghale, Ying Zhang Mazzu, Nagavarakishore Pillarsetty et al. · 2022 · Clinical Cancer Research
- Greatly Enhanced CTC Culture Enabled by Capturing CTC Heterogeneity Using a PEGylated PDMS–Titanium–Gold Electromicrofluidic Device with Glutathione-Controlled Gentle Cell ReleaseElyahb Allie Kwizera, Wenquan Ou, So Jeong Lee, Samantha Stewart, James G. Shamul, Jiangsheng Xu, Nancy S. Tait, Katherine H. R. Tkaczuk, Xiaoming He · 2022 · ACS Nano
- Preclinical models for drug discovery for metastatic disease.L. Wakefield, S. Agarwal, Kandice Tanner · 2023 · Cell
- Li–Fraumeni Syndrome Disease Model: A Platform to Develop Precision Cancer Therapy Targeting Oncogenic p53Ruoji Zhou, An Xu, Julian A. Gingold, Louise C. Strong, Ruiying Zhao, Dung‐Fang Lee · 2017 · Trends in Pharmacological Sciences
- Patient-derived xenografts as preclinical neuroblastoma modelsNoémie Braekeveldt, Daniel Bexell · 2017 · Cell and Tissue Research
- Preclinical Cancer Models and Biomarkers for Drug Development: New Technologies and Emerging ToolsMuthu Dhandapani, Aaron J. Goldman · 2017 · Journal of Molecular Biomarkers & Diagnosis
- Patient-derived organoids reflect the genetic profile of endometrial tumors and predict patient prognosisHege Fredriksen Berg, Marta Espevold Hjelmeland, Hilde Eide Lien, Heidi Espedal, Tina Fonnes, Aashish Srivastava, Tomasz Stokowy, Elin Strand, Olivera Bozickovic, Ingunn M. Stefansson et al. · 2021 · Communications Medicine
- Dual inhibition of AKT-mTOR and AR signaling by targeting HDAC3 in PTEN- or SPOP-mutated prostate cancerYan, Yuqian, An, Jian, Yang, Yinhui, Wu, Di, Bai, Yang, Cao, William, Ma, Linlin, Chen, Junhui, Yu, Zhendong, He, Yundong et al. · 2018 · EMBO Molecular Medicine
- Development of Prostate Cancer Organoid Culture Models in Basic Medicine and Translational ResearchMohamed Elbadawy, Amira Abugomaa, Hideyuki Yamawaki, Tatsuya Usui, Kazuaki Sasaki · 2020 · Cancers
- Curcumin and Andrographis Exhibit Anti-Tumor Effects in Colorectal Cancer via Activation of Ferroptosis and Dual Suppression of Glutathione Peroxidase-4 and Ferroptosis Suppressor Protein-1Katsuki Miyazaki, Caiming Xu, Mitsuo Shimada, Ajay Goel · 2023 · Pharmaceuticals
- A liquid biopsy for head and neck cancersHenri Schmidt, Arutha Kulasinghe, Chris Perry, Colleen C. Nelson, Chamindie Punyadeera · 2015 · Expert Review of Molecular Diagnostics
- Insights on CTC Biology and Clinical Impact Emerging from Advances in Capture TechnologyPatrick C. Bailey, Stuart S. Martin · 2019 · Cells
- Inhibition of O-GlcNAc Transferase Renders Prostate Cancer Cells Dependent on CDK9Harri M. Itkonen, Ninu Poulose, Rebecca E. Steele, Sara E. S. Martin, Zebulon G. Levine, Damien Y. Duveau, Ryan Carelli, Reema Singh, Alfonso Urbanucci, Massimo F. Loda et al. · 2020 · Molecular Cancer Research
- Liver Organoids: Formation Strategies and Biomedical ApplicationsXinglong Zhu, Bingqi Zhang, Yuting He, Ji Bao · 2021 · Tissue Engineering and Regenerative Medicine
- Scalable Production and Cryostorage of Organoids Using Core–Shell Decoupled Hydrogel CapsulesLu, Yen‐Chun, Fu, Dah‐Jiun, An, Duo, Chiu, Alan, Schwartz, Robert, Nikitin, Alexander Yu., Ma, Minglin · 2017 · Advanced Biosystems
- Modeling human disease using organotypic culturesPawel J. Schweiger, Kim Bak Jensen · 2016 · Current Opinion in Cell Biology
- Emerging Opportunities for Target Discovery in Rare CancersTanaz Sharifnia, Andrew Lee Hong, Corrie Painter, Jesse S. Boehm · 2017 · Cell chemical biology
- Patient-derived Models Reveal Impact of the Tumor Microenvironment on Therapeutic ResponseAyesha A. Shafi, Matthew Joseph Schiewer, Renée de Leeuw, Emanuela Dylgjeri, Peter A. McCue, Neelima Shah, Leonard G. Gomella, Costas D. Lallas, Edouard John Trabulsi, Margaret M. Centenera et al. · 2018 · European Urology Oncology
- Evaluation of anticancer agents using patient-derived tumor organoids characteristically similar to source tissuesHirosumi Tamura, Arisa Higa, Hirotaka Hoshi, Gen Hiyama, Nobuhiko Takahashi, Masae Ryufuku, Gaku Morisawa, Yuka Yanagisawa, Emi Ito, Junichi Imai et al. · 2018 · Oncology Reports
- CD4+ T cells induce rejection of urothelial tumors after immune checkpoint blockadeYuji Sato, Jennifer K. Bolzenius, Abdallah M. Eteleeb, Xinming Su, Christopher A. Maher, Jennifer K. Sehn, Vivek K. Arora · 2018 · JCI Insight
- Patient-derived tumor models: a more suitable tool for pre-clinical studies in colorectal cancerRizzo, Giulia, Bertotti, Andrea, Leto, Simonetta Maria, Vetrano, Stefania · 2021 · Journal of Experimental & Clinical Cancer Research
- Circulating Tumor Cells: Overview and Opportunities in CytologyKaitlin E. Sundling, Alarice Cheng-Yi Lowe · 2018 · Advances in Anatomic Pathology
- ZNF397 Deficiency Triggers TET2-Driven Lineage Plasticity and AR-Targeted Therapy Resistance in Prostate CancerYaru Xu, Yuqiu Yang, Zhaoning Wang, Martin Sjöström, Yuyin Jiang, Yitao Tang, Siyuan Cheng, Su Deng, Choushi Wang, Julisa Gonzalez et al. · 2024 · Cancer Discovery
- Impact of label-free technologies in head and neck cancer circulating tumour cellsArutha Kulasinghe, Liz Kenny, Chris Perry, Jean Paul Thiery, Lidija Jovanovic, Ian Vela, Colleen C. Nelson, Chamindie Punyadeera · 2016 · Oncotarget
- Preclinical models for precision oncologyMaider Ibarrola‐Villava, Andrès M.R. Cervantes, Alberto Bardelli · 2018 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
- Modeling liver cancer and therapy responsiveness using organoids derived from primary mouse liver tumorsWanlu Cao, Jiaye Liu, Ling Wang, Meng Li, Monique M. A. Verstegen, Yuebang Yin, Buyun Ma, Kan Chen, Michiel Bolkestein, Dave Sprengers et al. · 2018 · Carcinogenesis
- Developing liver organoids from induced pluripotent stem cells (iPSCs): An alternative source of organoid generation for liver cancer researchRomario Nguyen, Sarah Da Won Bae, Liang Qiao, Jacob George · 2021 · Cancer Letters
- The Role of the p53 Protein in Stem-Cell Biology and Epigenetic RegulationArnold J. Levine, Anna M. Puzio‐Kuter, Chang S. Chan, Pierre L. Hainaut · 2016 · Cold Spring Harbor Perspectives in Medicine
- Papillary thyroid cancer organoids harboring BRAFV600E mutation reveal potentially beneficial effects of BRAF inhibitor-based combination therapiesDong Chen, Xi Su, Lizhang Zhu, Jia Hao, Bin Han, Haibo Chen, Qingzhuang Liang, Chenchen Hu, Hao Yang, Lisa Liu et al. · 2023 · Journal of Translational Medicine
- AZGP1P2/UBA1/RBM15 Cascade Mediates the Fate Determinations of Prostate Cancer Stem Cells and Promotes Therapeutic Effect of Docetaxel in Castration-Resistant Prostate Cancer via TPM1 m6A ModificationHong Wang, Ji Liu, Xiaojun Zhu, Bin Yang, Zuping He, Xudong Yao · 2023 · Research
- CRISPR therapeutic tools for complex genetic disorders and cancer (Review)Stella Baliou, Maria Adamaki, Anthony M. Kyriakopoulos, Demetrios A. Spandidos, Mihalis I. Panayiotidis, Ioannis Christodoulou, Vassilis C. Zoumpourlis · 2018 · International Journal of Oncology
- Abi1 loss drives prostate tumorigenesis through activation of EMT and non-canonical WNT signalingDisharee Nath, Xiang Li, Claudia Mondragon, Dawn E. Post, Ming Chen, Julie R. White, Anita Hryniewicz‐Jankowska, Tiffany N. Caza, Vladimir A. Kuznetsov, Heidi Hehnly et al. · 2019 · Cell Communication and Signaling
- Establishment of novel long-term cultures from EpCAM positive and negative circulating tumour cells from patients with metastatic gastroesophageal cancerDaniel Brungs, Elahe Minaei, Ann‐Katrin Piper, Jay R. Perry, Ashleigh Splitt, Martin Carolan, Shantay Ryan, Xiao Wu, Stéphanie Corde, Moeava Tehei et al. · 2020 · Scientific Reports
- Organoid Transplantation Can Improve Reproductive Prognosis by Promoting Endometrial Repair in MiceHuixing Zhang, Dabao Xu, Yan Li, Jianqiang Lan, Yu Zhu, Jia Cao, Mingyue Hu, Juanjuan Yuan, Jin Peng He, Gang Li et al. · 2022 · International Journal of Biological Sciences
- Studying cancer metastasis: Existing models, challenges and future perspectivesDenise M.S. van Marion, Urszula Domańska, Hetty Timmer‐Bosscha, Annemiek Walenkamp · 2015 · Critical Reviews in Oncology/Hematology
- Choosing wisely – Preclinical test models in the era of precision medicineKonrad Friedrich Klinghammer, Wolfgang Walther, Jens Hoffmann · 2017 · Cancer Treatment Reviews
- Functional Optical Imaging of Primary Human Tumor Organoids: Development of a Personalized Drug ScreenAlex J. Walsh, Rebecca S. Cook, Melissa C. Skala · 2017 · Journal of Nuclear Medicine
- A Fast and Simple Fluorometric Method to Detect Cell Death in 3D Intestinal OrganoidsKonstantin J. Bode, Stefanie Mueller, Matthias Schweinlin, Marco Metzger, Thomas Brunner · 2019 · BioTechniques
- Organoid culture system for patient-derived lung metastatic osteosarcomaAina He, Yujing Huang, Wanying Cheng, Deng Zhang, Weiwei He, Yueqing Bai, Chao Gu, Zhongping Ma, Zhenfang He, Guifan Si et al. · 2020 · Medical Oncology
- Integration of pan-omics technologies and three-dimensional in vitro tumor models: an approach toward drug discovery and precision medicineAnmi Jose, Pallavi Kulkarni, Jaya Thilakan, Murali Munisamy, Anvita Gupta Malhotra, Jitendra Singh, Ashok Kumar, Vivek M. Rangnekar, Neha Arya, Mahadev Rao · 2024 · Molecular Cancer
- Leveraging 3D cell culture and AI technologies for next-generation drug discoveryRaj Dave, Kshipra Pandey, Ritu Bhaumik Patel, Nidhi Gour, Dhiraj Devidas Bhatia · 2025 · Cell Biomaterials
- 3D Miniaturization of Human Organs for Drug DiscoveryJoseph Park, Isaac Wetzel, Didier Dréau, Hansang Cho · 2017 · Advanced Healthcare Materials
- A New Era of Prostate Cancer Precision MedicineAdil Malik, Srilakshmi Srinivasan, Jyotsna Batra · 2019 · Frontiers in Oncology
- Pancreatic Ductal Adenocarcinoma (PDAC) Organoids: The Shining Light at the End of the Tunnel for Drug Response Prediction and Personalized MedicinePierre‐Olivier Frappart, Thomas G. Hofmann · 2020 · Cancers
- Microfluidic techniques for isolation, formation, and characterization of circulating tumor cells and clustersCeline Macaraniag, Qiyue Luan, Jian Zhou, Ian Papautsky · 2022 · APL Bioengineering
- Living biobank-based cancer organoids: prospects and challenges in cancer researchHaixin Li, Hongkun Liu, Kexin Chen · 2022 · Cancer Biology and Medicine
- Label-Free Enrichment and Molecular Characterization of Viable Circulating Tumor Cells from Diagnostic Leukapheresis ProductsAndré Franken, Christiane Driemel, Bianca Behrens, Franziska Meier-Stiegen, Volker Endris, Albrecht Stenzinger, Dieter Niederacher, Johannes Fischer, Nikolas Hendrik Stoecklein, Eugen Ruckhaeberle et al. · 2019 · Clinical Chemistry
- Establishing Pure Cancer Organoid Cultures: Identification, Selection and Verification of Cancer Phenotypes and GenotypesNina Wallaschek, Carolin Niklas, Malvika Pompaiah, Armin Wiegering, Christoph‐Thomas Germer, Stefan Kircher, Stephanie Brändlein, Katja Maurus, Andreas Rosenwald, Helen H.N. Yan et al. · 2019 · Journal of Molecular Biology
- Therapeutic applications of PARP inhibitors in ovarian cancerHongyu Xie, Wenjie Wang, Bairong Xia, Weilin Jin, Ge Lou · 2020 · Biomedicine & Pharmacotherapy
- ERG orchestrates chromatin interactions to drive prostate cell fate reprogrammingFei Li, Qiuyue Yuan, Wei Di, Xinyi Xia, Zhuang Liu, Ninghui Mao, Lin Li, Chunfeng Li, Juan He, Yunguang Li et al. · 2020 · Journal of Clinical Investigation
- An update of label-free protein target identification methods for natural active productsZhao Cui, Caifeng Li, Peng Chen, Hongjun Yang · 2022 · Theranostics
- A suspension technique for efficient large-scale cancer organoid culturing and perturbation screensStacey Price, Shriram G. Bhosle, Emanuel Gonçalves, Xiaodun Li, Dylan Peter McClurg, Syd Barthorpe, Alexandra Beck, Caitlin Hall, Howard W. Lightfoot, Luke Farrow et al. · 2022 · Scientific Reports
- Flourishing tumor organoids: History, emerging technology, and applicationQian Yang, Mengmeng Li, Xinming Yang, Zian Xiao, Xinying Tong, Ayinuer Tuerdi, Shisheng Li, Lanjie Lei · 2023 · Bioengineering & Translational Medicine
- Organoids as Innovative Models for Bone and Joint DiseasesJie Huang, Lingqiang Zhang, Aiping Lü, Chao Liang · 2023 · Cells
- Engineered biomimetic hydrogels for organoidsYihan Li, Qimanguli Saiding, Zhen Wang, Wenguo Cui · 2023 · Progress in Materials Science
- Recent advances in the biology of human circulating tumour cells and metastasisSofia Gkountela, Barbara Maria Szczerba, Cinzia Donato, Nicola Aceto · 2016 · ESMO Open
- Gambogic acid inhibits thioredoxin activity and induces ROS-mediated cell death in castration-resistant prostate cancerHong Pan, Keith H. Jansson, Michael L. Beshiri, JuanJuan Yin, Lei Fang, Supreet Agarwal, Holly M. Nguyen, Eva Corey, Ying Zhang, Jie Liu et al. · 2017 · Oncotarget
- Development of Patient-Derived Preclinical Platform for Metastatic Pancreatic Cancer: PDOX and a Subsequent Organoid Model System Using Percutaneous Biopsy SamplesSung Yong Choi, A-Ra Jeon, Min Kyeong Kim, Yu‐Sun Lee, Ji-Eun Im, Jung-Wook Koh, Sung‐Sik Han, Sun‐Young Kong, Kyong‐Ah Yoon, Young Hwan Koh et al. · 2019 · Frontiers in Oncology
- Emerging roles of prominin-1 (CD133) in the dynamics of plasma membrane architecture and cell signaling pathways in health and diseasePetr Pleskač, Christine A. Fargeas, Renata Veselská, Denis Corbeil, Jan Skoda · 2024 · Cellular & Molecular Biology Letters
- Human ex vivo 3D bone model recapitulates osteocyte response to metastatic prostate cancerSaba Choudhary, Poornema Ramasundaram, Eugenia Dziopa, Ciaran M. Mannion, Yair Kissin, Lucas Tricoli, Christopher Albanese, Woo Lee, Jenny Zilberberg · 2018 · Scientific Reports
- Ex vivo culture of circulating tumour cells derived from non-small cell lung cancerJoanna Kapeleris, Arutha Kulasinghe, Majid Ebrahimi Warkiani, Connor Gerard O’Leary, Ian Vela, Paul Leo, Peter R. Sternes, Kenneth John O'Byrne, Chamindie Punyadeera · 2020 · Translational Lung Cancer Research
- Resistance to Antiandrogens in Prostate Cancer: Is It Inevitable, Intrinsic or Induced?Norman J. Maitland · 2021 · Cancers
- Short-Term Ex Vivo Culture of CTCs from Advance Breast Cancer Patients: Clinical ImplicationsNuria Carmona-Ule, Miriam González-Conde, Carmen Abuín, Juan Fernando Cueva, Patricia Palacios, Rafael López‐López, Clotilde Costa, Ana Belén Dávila-Ibáñez · 2021 · Cancers
- Functional 3-Dimensional Retinal Organoids: Technological Progress and Existing ChallengesMeimanat Fathi, Cody T. Ross, Zohreh Hosseinzadeh · 2021 · Frontiers in Neuroscience
- Redox modulation of vitagenes via plant polyphenols and vitamin D: Novel insights for chemoprevention and therapeutic interventions based on organoid technologyMaria Concetta Scuto, Angela Trovato Salinaro, Isabella Caligiuri, Maria Laura Ontario, Valentina Greco, Nello Sciuto, Roberto Crea, Edward J. Calabrese, Flavio Rizzolio, Vincenzo Canzonieri et al. · 2021 · Mechanisms of Ageing and Development
- Gastric Organoids: Progress and Remaining ChallengesMin-Jiao Pang, Joseph Burclaff, Ramon U. Jin, Mahliyah Adkins-Threats, Luciana H. Osaki, Yunan Han, Jason C. Mills, Zhi‐Feng Miao, Zhen-Ning Wang · 2021 · Cellular and Molecular Gastroenterology and Hepatology
- Preclinical models of prostate cancer — modelling androgen dependency and castration resistance in vitro, ex vivo and in vivoLucas Germain, Camille Lafront, Virginie Paquette, Bertrand Neveu, Jean‐Sébastien Paquette, Frédéric Pouliot, Étienne Audet‐Walsh · 2023 · Nature Reviews Urology
- Organotypic three-dimensional cancer cell cultures mirror drug responses<i>in vivo</i>: lessons learned from the inhibition of EGFR signalingJacobi, Nico, Seeboeck, Rita, Hofmann, Elisabeth, Schweiger, Helmut, Smolinska, Veronika, Mohr, Thomas, Boyer, Alexandra, Sommergruber, Wolfgang, Lechner, Peter, Pichler-Huebschmann, Corina et al. · 2017 · Oncotarget
- Recent advances in prostate cancer research: large-scale genomic analyses reveal novel driver mutations and DNA repair defectsSander B. Frank, Peter S. Nelson, Valeri I. Vasioukhin · 2018 · F1000Research
- Models for Understanding Resistance to Chemotherapy in Liver CancerJosé J.G. Marı́n, Elisa Herráez, Elisa Lozano, Rocı́o I.R. Macı́as, Óscar Briz · 2019 · Cancers
- Patient-derived organoids (PDOs) as a novel in vitro model for neuroblastoma tumoursPina Fusco, B. Parisatto, Elena Rampazzo, Luca Persano, Chiara Frasson, Annamaria Di Meglio, A Leslz, L. Santoro, Barbara Cafferata, Angelica Zin et al. · 2019 · BMC Cancer
- Targeting eIF4A-Dependent Translation of KRAS Signaling MoleculesSingh, Kamini, Lin, Jianan, Lecomte, Nicolas, Mohan, Prathibha, Gokce, Askan, Sanghvi, Viraj R., Jiang, Man, Grbovic-Huezo, Olivera, Burčul, Antonija, Stark, Stefan G. et al. · 2021 · Cancer Research
- Dual targeting of MAPK and PI3K pathways unlocks redifferentiation of Braf-mutated thyroid cancer organoidsHélène Lasolle, Andréa Alex Schiavo, Adrien Tourneur, Pierre Gillotay, Bárbara F. Fonseca, Lucieli Ceolin, Olivier Monestier, Benilda Aganahi, Laura Chomette, Marina M. L. Kizys et al. · 2023 · Oncogene
- The viable circulating tumor cells with cancer stem cells feature, where is the way out?Yang Luo, Jin Quan Cheng, X. Feng, Songbing He, Yawei Wang, Q. Huang · 2018 · Journal of Experimental & Clinical Cancer Research
- Malignant ascites-derived organoid (MADO) cultures for gastric cancer in vitro modelling and drug screeningJie Li, Huawei Xu, Lixing Zhang, Lele Song, Dan Feng, Xiaobo Peng, Meihong Wu, Yang Zou, Bin Wang, Lixing Zhan et al. · 2019 · Journal of Cancer Research and Clinical Oncology
- Microfluidics for personalized drug screening of cancerNishanth Venugopal Menon, Su Bin Lim, Chwee Teck Lim · 2019 · Current Opinion in Pharmacology